• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
China Interventional Cardiovascular Device Industry Report, 2013-2015 - Product Image

China Interventional Cardiovascular Device Industry Report, 2013-2015

  • Published: November 2013
  • Region: China
  • 98 Pages
  • Research In China
China's Cardiovascular Stent Market Size Grew At An CAGR Of 20.3% In 2007-2012

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun
  • Johnson & Johnson
  • Lepu Medical
  • Lifetech Scientific
  • MicroPort
  • MORE

With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People's Republic of China, in 2012 cardiovascular disease deaths in China reached 3.5 million. The fast growing number of heart patients stimulated rapid growth in Chinese demand for interventional cardiac operation and coronary stent. China's PCI (percutaneous coronary intervention) surgeries increased from 25,000 cases in 2002 to about 531,000 cases in 2012; the number of coronary stent implantation rose from 40,000 units in 2002 to approximately 640,000 units in 2012. In 2007-2012 China's cardiovascular stent market size grew at an AAGR of 20.3%.

In China, interventional cardiovascular devices are dominated by cardiovascular stent. Currently, the top three companies in China's coronary stent market are respectively MicroPort, Lepu Medical and JW Medical; while supporting auxiliary devices such as catheter and guide wire feature low localization rate, mainly dependent on imports. In 2012, Chinese enterprises accounted for 66.8% of Chinese interventional cardiovascular device market share, followed READ MORE >

1. Overview of Interventional Cardiovascular Device Industry
1.1 Definition
1.2 Product Types and Applications
1.3 Industry Chain

2. Status Quo of China Interventional Cardiovascular Device Industry
2.1 Overview
2.2 Market Demand
2.3 Import and Export
2.4 Competition Pattern
2.5 Profit
2.6 Entry Barriers
2.6.1 Technology
2.6.2 Talent
2.6.3 Patent
2.6.4 Policy
2.6.5 Market Access

3. Development Environment for China Interventional Cardiovascular Device Industry
3.1 Policy Environment
3.1.1 Regulatory Policy
3.1.2 Industry Policy
3.2 Upstream and Downstream Sectors
3.2.1 Upstream
3.2.2 Downstream

4. Market Segments
4.1 Coronary Stent
4.1.1 Market Profile
4.1.2 Drug-Eluting Stent
4.1.3 Bare Metal Stent
4.1.4 Bioabsorbable Stent
4.2 Balloon Catheter
4.2.1 Market Profile
4.2.2 Supply and Demand
4.3 Catheter
4.3.1 Market Profile
4.3.2 Sales
4.4 Guide Wire
4.4.1 Market Profile
4.4.2 Sales
4.5 Sheath Group and Auxiliary Devices
4.5.1 Market Profile
4.5.2 Sales

5. Foreign Companies
5.1 Johnson & Johnson
5.1.1 Profile
5.1.2 Operation
5.1.3 Interventional Cardiovascular Device Business
5.1.4 Operation in China
5.2 Medtronic
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Operation in China
5.3 Boston Scientific
5.3.1 Profile
5.3.2 Operation
5.3.3 Operation in China
5.4 Abbott Laboratories
5.4.1 Profile
5.4.2 Operation
5.4.3 Operation in China
5.5 B. Braun
5.5.1 Profile
5.5.2 Operation
5.5.3 Operation in China

6. Chinese Companies
6.1 MicroPort
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure
6.1.4 Gross Margin
6.1.5 R&D and Investment
6.1.6 Interventional Cardiovascular Device Business
6.1.7 Forecast and Outlook
6.2 Lepu Medical
6.2.1 Profile
6.2.2 Operation
6.2.3 Revenue Structure
6.2.4 Gross Margin
6.2.5 R&D and Investment
6.2.6 Interventional Cardiovascular Device Business
6.2.7 Forecast and Outlook
6.3 Lifetech Scientific
6.3.1 Profile
6.3.2 Operation
6.3.3 Revenue Structure
6.3.4 Gross Margin
6.3.5 R&D and Investment
6.3.6 Interventional Cardiovascular Device Business
6.4 JW Medical
6.4.1 Profile
6.4.2 Operation
6.4.3 Development
6.5 Liaoning Bio-medical
6.5.1 Profile
6.5.2 Operation
6.5.3 Development
6.6 OrbusNeich
6.6.1 Profile
6.6.2 Operation
6.6.3 Development
6.7 Sinomed
6.7.1 Profile
6.7.2 Operation
6.7.3 Development
6.8 SCW Medicath
6.8.1 Profile
6.8.2 Operation
6.9 Amtech Biotech
6.9.1 Profile
6.9.2 Operation
6.10 Starway Medical

Selected Charts

Interventional Cardiovascular Device Types and Functions
Cardiovascular Stent Types and Characteristics
China Interventional Cardiovascular Device Industry Chain
Revenue and Growth Rate of China Medical Device Industry, 2006-2012
China's Cardiovascular Stent Market Size and Growth Rate, 2007-2012
PCI Surgical Cases in China, 2002-2012
Number of Coronary Stent Implantation in China, 2002-2012
Import Ratio and Import Prices of China's Major Interventional Medical Devices, 2008
Chinese Interventional Cardiovascular Device Market Share, 2012
Gross Margin of China's Major Interventional Cardiovascular Device Companies, 2007-2012
Business Model of China Interventional Cardiovascular Device Industry
Key Policies for China Interventional Cardiovascular Device Industry, 2006-2012
Number of Hospitals in China (by Grade), 2006-May 2013
Total Medical & Health Costs and % in GDP in China, 2000-2012
Population of 65-year-old People and % in Total Population in China, 1982-2012
China's Per Capita Disposable Income of Urban Residents and Per Capita Net Income of Rural Households, 2001-2012
China's Medical Care Coverage and Spending Levels
Interventional Operation Medical Insurance Payout Ratio in Beijing, Shanghai and Guangzhou, 2011
China's Coronary Stent Market Size, 2007-2015E
List of Drug-eluting Stent Products in Chinese Market, 2010
Maximum Retail Price of Heart Stent Products in Shanghai, 2012
List of Domestic Second-generation Drug-eluting Stent Products, 2013
Interventional Supplies Bidding Price of A Hospital in Shanghai, 2012
List of Some Bare Metal Stents in Chinese Market, 2010
Bare Metal Stent Usage in China, 2009-2012
Bioabsorbable Stent Usage in China, 2009-2012
China's Interventional Cardiovascular Balloon Catheter Market Size, 2009-2012
China's Demand for Coronary Balloon Catheter, 2002-2012
Balloon Catheter Purchase Prices in Chinese Market, 2010
List of Some Rapid Exchange Balloon Dilatation Catheters in Chinese Market, 2010
Maximum Retail Price of Catheter Products in Shanghai, 2012
China's Interventional Cardiovascular Catheter Market Size, 2009-2012
Catheter Purchase Prices in Chinese Market, 2010
Listing of Guiding Catheter Products in Chinese Market, 2010
Maximum Retail Price of Catheter Products in Shanghai, 2012
China's Interventional Cardiovascular Guidewire Market Size, 2009-2012
Guidewire Purchase Prices in Chinese Market, 2010
List of Some Guidewire Products in Chinese Market, 2010
Market Size of Interventional Cardiovascular Sheath Group and Auxiliary Devices in China, 2009-2012
Average Purchase Prices of Sheath Group and Auxiliary Devices in Chinese Market, 2010
Revenue and Net Income of Johnson & Johnson, 2008-2012
Revenue Structure of Johnson & Johnson (by Product), 2012
Revenue of Cordis, 2007-2011
Johnson & Johnson Companies in China and Their Main Products
Revenue and Total Profit of Johnson & Johnson Medical (Suzhou), 2008-2009
Gross Margin of Johnson & Johnson Medical (Suzhou), 2008-2009
Total Assets and Total Liabilities of Johnson & Johnson Medical (Suzhou), 2008-2009
Revenue and Net Income of Medtronic, FY2008-FY2013
Gross Margin of Medtronic, FY2009-FY2013
Medtronic's Revenue from Cardiovascular Products and % of Total Revenue, FY2008-FY2011
Revenue Structure of Medtronic (by Product), FY2011-FY2013
Revenue Structure of Medtronic (by Region), FY2009-FY2013
Revenue and Total Profit of Medtronic (Shanghai), 2007-2008
Gross Margin of Medtronic (Shanghai), 2007-2008
Total Assets and Total Liabilities of Medtronic (Shanghai), 2007-2008
Revenue and Net Income of Boston Scientific, 2008-2012
Revenue Structure of Boston Scientific (by Product), 2009-2012
Revenue and Net Income of Abbott Laboratories, 2008-2012
Abbott's Revenue from Vascular Device Division and % of Total Revenue, 2008-2012
Revenue and Growth Rate of B. Braun Aesculap Surgical Instrument Sector, 2006-2012
Revenue and Net Income of MicroPort, 2008-2013
Revenue Structure of MicroPort (by Product), 2012
Revenue Structure of MicroPort (by Region), 2008-2012
Gross Margin of MicroPort, 2008-2013
R&D Costs and % of Total Revenue of MicroPort, 2008-2012
MicroPort's Competitive Advantage in Field of Heart Drug Stent
Key Financial Indicators of DongGuan Kewei MedicalInstrument, 2010-2011
Revenue and Net Income of MicroPort, 2012-2015
Revenue and Net Income of Lepu Medical, 2008-2013
Revenue Structure of Lepu Medical (by Product), 2008-2013
Operating Revenue Structure of Lepu Medical (by Region), 2008-2013
Gross Margin of Lepu Medical, 2008-2013
Gross Margin of Lepu Medical (by Product), 2008-2013
R&D Costs and % of Total Revenue of Lepu Medical, 2008-2012
Revenue and Net Income of Lepu Medical, 2012-2015
Revenue and Net Income of Lifetech Scientific, 2009-2013
Revenue Structure of Lifetech Scientific (by Product), 2010-2013
Revenue Structure of Lifetech Scientific (by Region), 2010-2012
Gross Margin of Lifetech Scientific, 2009-2013
R&D Costs and % of Total Revenue of Lifetech Scientific, 2010-2013
CHD (Congenital Heart Disease) Revenue of Lifetech Scientific, 2010-2013
Peripheral Vascular Revenue of Lifetech Scientific, 2010-2013
Revenue and Total Profit of JW Medical, 2007-2011
Gross Margin of JW Medical, 2007-2011
Total Assets and Total Liabilities of JW Medical, 2007-2011
Revenue and Total Profit of Liaoning Bio-medical, 2008-2009
Gross Margin of Liaoning Bio-medical, 2008-2009
Total Assets and Total Liabilities of Liaoning Bio-medical, 2008-2009
Revenue and Total Profit of OrbusNeich, 2007-2011
Gross Margin of OrbusNeich, 2007-2011
Total Assets and Total Liabilities of OrbusNeich, 2007-2011
Revenue and Total Profit of Sinomed, 2008-2011
Gross Margin of Sinomed, 2008-2011
Total Assets and Total Liabilities of Sinomed, 2008-2011
Revenue and Total Profit of SCW Medicath, 2007-2011
Gross Margin of SCW Medicath, 2007-2011
Total Assets and Total Liabilities of SCW Medicath, 2007-2011
Export Delivery Value and % of Total Revenue of SCW Medicath, 2005-2009
Revenue and Total Profit of Amtech Biotech, 2008-2012
Total Assets and Total Liabilities of Amtech Biotech, 2008-2012
Revenue and Total Profit of Starway Medical, 2009-2011
Gross Margin of Starway Medical, 2009-2011
Total Assets and Total Liabilities of Starway Medical, 2009-2011

- Abbott Laboratories
- Amtech Biotech
- B. Braun
- Boston Scientific
- JW Medical
- Johnson & Johnson
- Lepu Medical
- Liaoning Bio-medical
- Lifetech Scientific
- Medtronic
- MicroPort
- OrbusNeich
- SCW Medicath
- Sinomed
- Starway Medical

Note: Product cover images may vary from those shown

ALSO AVAILABLE IN THE FOLLOWING LANGUAGES

RELATED PRODUCTS

Our Clients

Our clients' logos